Marco Tampellini

The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

Giovanni Fucà, Vincenzo Guarini, Carlotta Antoniotti et al. · British Journal of Cancer · 2020 · 315 citations · Full text

Circadian Rhythm in Rest and Activity: A Biological Correlate of Quality of Life and a Predictor of Survival in Patients with Metastatic Colorectal Cancer

Pasquale F. Innominato, C. Focan, Thierry Gorlia et al. · Cancer Research · 2009 · 245 citations · Full text

Biological Correlate, Quality Of Life, Cancer Management +21

Phase III Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin As First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group

Sylvie Giacchetti, Georg A. Bjarnason, Carlo Garufi et al. · Journal of Clinical Oncology · 2006 · 220 citations · Full text

Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study

Daniele Santini, Marco Tampellini, Bruno Vincenzi et al. · Annals of Oncology · 2012 · 129 citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Medicine +7

Prediction of overall survival through circadian rest‐activity monitoring during chemotherapy for metastatic colorectal cancer

Pasquale F. Innominato, Sylvie Giacchetti, Georg A. Bjarnason et al. · International Journal of Cancer · 2012 · 128 citations · Full text